Hydrocarbons, silicon-containing compounds and pesticides

  • Patrick C. D’haese
  • Monique M. Elseviers
  • Muhammed Yaqoob
  • Marc E. De Broe

Summary

Environmental/industrial exposure to heavy metals, light hydrocarbons, pesticides and silicon-containing compounds all have been associated with the development and/or progression of renal failure. Occupational exposure to heavy metals, more particularly lead, cadmium and mercury has been linked with the development of acute or chronic renal failure. Indeed, the current literature contains a growing body of information linking solvent exposure with renal injury. To what extent exposure to environmental/occupational contaminants such as pesticides play either a causal or contributive role in the development of chronic renal failure is less clear. Recently reported observations suggest either a primary or secondary role of silicon-containing compounds in the development of anti-neutrophil cytoplasmic antibody-positive rapid progressive glomerulonephritis and Wegener’s granulomatosis. Such observations deserve further confirmation as do recent studies suggesting a particular sensitivity of the diabetic kidney for the damaging effects of certain occupational exposures.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Croll DG. The incidence of chronic nephritis amongst young people in Queensland. Med J Aust 1929; 2: 144–145.Google Scholar
  2. 2.
    Pederen LM. Biological studies in human exposure to and poisoning with organic solvents. Pharmacol Toxicol 1987; 3: 1–38.Google Scholar
  3. 3.
    Porter GA. The treatment of ethylene glycol poisoning simplified. N Eng J Med 1988; 319(2): 109–110.Google Scholar
  4. 4.
    Roy AT, Brautbar N, Lee DBN. Hydrocarbons and renal failure. Nephron 1991; 58: 385–392.PubMedGoogle Scholar
  5. 5.
    Sprecace GA. Idiopathic pulmonary hemosiderosis. Am Rev Resp Dis 1963; 8: 330–337.Google Scholar
  6. 6.
    Yaqoob M, Bell GM, Stevenson A, Mason H, Percy DF. Renal impairment with hydrocarbon exposure. Quart J Med 1993; 86: 165–174.PubMedGoogle Scholar
  7. 7.
    Krusell L, Nielsen HK, Baelum J, Lundqvist G, Omland O, Vaeth M, Husted SE, Mogensen CE, Geday E. Renal effects of chronic exposure to organic solvents: a clinically controlled trial. Acta Med Scand 1985; 218: 323–327.PubMedGoogle Scholar
  8. 8.
    Enarson DA, Chan-Yeung M, Embree V, Wang R, Schulzer M. Occupational exposure to chlorophenates. Scand J Work Environ Health 1986; 12: 144–148.PubMedGoogle Scholar
  9. 9.
    Ng TP, Ong SG, Lam WK, Jones MG, Cheung CK, Ond CN. Urinary levels of proteins and metabolites in workers exposed to toluene. Int Arch Occup Environ Health 1990; 62: 43–46.PubMedGoogle Scholar
  10. 10.
    Hotz P, Pilliod J, Bernard A, Berode M, Rey F, Mazzocato C, Guillemin M, Boillat MA. Hydrocarbon exposure, hypertension and kidney function tests. Int Arch Occup Environ Health 1990; 62: 501–508.CrossRefPubMedGoogle Scholar
  11. 11.
    Lauwerys R, Herbrand J, Buchet JP, Bernard A, Gaussin J. Health surveillance of workers exposed to tetrachloroethylene in dry-cleaning shops. Int Arch Occup Environ Health 1983; 52: 69–77.CrossRefPubMedGoogle Scholar
  12. 12.
    Mutti A, Lucertini S, Falzoi M, Cavatorta A, Franchini I. Organic solvents and chronic glomerulonephritis: a cross-sectional study with negative findings for aliphatic and alicyclic C5–C7 hydrocarbons. J Appl Toxicol 1981; 1(4): 224–226.PubMedGoogle Scholar
  13. 13.
    Viau C, Bernard A, Lauwerys R, Buchet JP, Quaeghebeur L, Cornu L, Cornu M, Phillips SC, Mutti A, Lucertini S, Francini I. A cross-sectional survey of kidney function in refinery employees. Am J Ind Med 1987; 11: 177–187.PubMedGoogle Scholar
  14. 14.
    Mutti A, Alinovi R, Bergamaschi E, Giagini C, Cavazinni S, Franchini I, Lauwerys RR, Bernard AM, Roels H, Gelpi E, Rosello J, Ramis I, Price RG, Taylor SA, De Broe ME, Nuyts GD, Stolte H, Fels LM, Herbort C. Nephropathies and exposure to perchloroethylene in dry cleaners. Lancet 1992; 340: 189–193.CrossRefPubMedGoogle Scholar
  15. 15.
    Zimmerman SW, Groehler K, Beirne GJ. Hydrocarbon exposure and chronic glomerulonephritis. Lancet 1975; 2: 199–201.PubMedGoogle Scholar
  16. 16.
    Lagrue G, Kamalodine T, Hirbec G et al. Rôle de ľinhalation de substances toxiques dans la genèse des glomérulonéphritis. Nouv Press Med 1977; 6: 3609–3613.Google Scholar
  17. 17.
    Ravnskov U. Exposure to organic solvents — a missing link in poststreptococcal glomerulonephritis? Acta Med Scand 1978; 203: 351–356.PubMedGoogle Scholar
  18. 18.
    Ravnskov U, Forsberg B, Skerfving S. Glomerulonephritis and exposure to organic solvents: a case control study. Acta Med Scan 1979; 205: 575–579.Google Scholar
  19. 19.
    Finn R, Fennerty AG, Ahmad R. Hydrocarbon exposure and glomerulonephritis. Clin Nephrol 1980; 14(4): 173–175.Google Scholar
  20. 20.
    Van der Laan G. Chronic glomerulonephritis and organic solvents: a case control study. Int Arch Occup Environ Health 1980; 47: 1–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Ravnskov U, Lundström S, Nordén A. Hydrocarbon exposure and glomerulonephritis evidence from patients’ occupations. Lancet 1983; 2: 1214–1216.PubMedGoogle Scholar
  22. 22.
    Bell GM, Gordon ACH, Lee P, Doig A, MacDonald MK, Thomson D, Anderton J, Robson JS. Proliferative glomerulonephritis and exposure to organic solvents. Nephron 1985; 40: 161–165.PubMedGoogle Scholar
  23. 23.
    Harrison DJ, Thomson D, MacDonald MK. Membranous glomerulonephritis. J Clin Pathol 1986; 39: 167–171.PubMedGoogle Scholar
  24. 24.
    Harrington JM, Whitby H, Gray CN, Reid FJ, Aw TC, Waterhouse JA. Renal disease and occupational exposure to organic solvents: a case referent approach. Brit J Ind Med 1989; 46: 643–650.Google Scholar
  25. 25.
    Porro A, Lomonte C, Coratelli P, Passavanti G, Maria Ferri G, Assennato G. Chronic glomerulonephritis and exposure to solvents: a case referent study. Brit J Ind Med 1992; 49: 738–742.Google Scholar
  26. 26.
    Yaqoob M, Bell GM, Percy D, Finn R. Primary glomerulonephritis and hydrocarbon exposure: a case control study and literature review. Quart J Med 1992; 301: 409–418.Google Scholar
  27. 27.
    Yaqoob M, Patrick AW, McClelland P, Stevenson A, Mason H, Percy DF, White MC, Bell GM. Occupational hydrocarbon exposure in diabetic nephropathy. Diabetic Med 1994; 11(8): 789–793.PubMedGoogle Scholar
  28. 28.
    Nuyts GD, Van Vlem E, Thys J, De Leersnijder D, D’Haese PC, Elseviers MM, De Broe ME. New occupational risk factors for chronic renal failure. Lancet 1995; 346: 7–11.CrossRefPubMedGoogle Scholar
  29. 29.
    Stengel B, Cénée S, Limasset JC, Protois JC, Marcelli A, Brochard P, Hémon D. Organic solvent exposure may increase the risk of glomerular nephropathies with chronic renal failure. Int J Epidem 1995; 24: 427–434.Google Scholar
  30. 30.
    Churchill DN, Fine A, Gault MH. Association between hydrocarbon exposure and glomerulonephritis. An appraisal of the evidence. Nephron 1983; 33: 169–172.PubMedGoogle Scholar
  31. 31.
    Angell M. The interpretation of epidemiologic studies. N Engl J Med 1990; 323: 823–825.PubMedGoogle Scholar
  32. 32.
    Bell GM, Doig D, Thompson D, Anderton JL, Robson JS. End-stage renal disease associated with occupational exposure into organic solvents. Proc EDTA-ERA 1985; 22: 725–729.Google Scholar
  33. 33.
    Ravnskov U. Influence of hydrocarbon exposure on the course of glomerulonephritis. Nephron 1986; 42: 156–160.PubMedGoogle Scholar
  34. 34.
    Ravnskov U. Hydrocarbon exposure may cause glomerulonephritis and worsen renal function: evidence based on Hill’s criteria for causality. Q J Med 2000; 93: 551–556.Google Scholar
  35. 35.
    Ravnskov U. Hydrocarbons may worsen renal function in glomerulonephritis: A meta-analysis of the case-control studies. Am J Ind Med 2000; 37: 599–506.Google Scholar
  36. 36.
    Salant DJ. Immunopathogenesis of crescentic glomerulonephritis and lung purpura. Kidney Int 1987; 32: 408–425.PubMedGoogle Scholar
  37. 37.
    Kalluri R, Gattone VH 2nd, Noelken ME, Hudson BG. The a 3 chain of type IV collagen induces autoimmune Goodpasture syndrome. Proc Natl Acad Sci USA 1994; 91(13): 6201–6205.PubMedGoogle Scholar
  38. 38.
    Daniell WE, Couser WG, Rosenstock L. Occupational solvent exposure and glomerulonephritis. A case report and review of the literature. JAMA 1988; 259: 2280–2283.CrossRefPubMedGoogle Scholar
  39. 39.
    Narvarte J, Sabe SR, Ramirez G. Occupational exposure to organic solvents causing chronic tubulointerstitial nephritis. Arch Intern Med 1989; 149: 154–158.CrossRefPubMedGoogle Scholar
  40. 40.
    Cameron JS. Tubular and interstitial factors in the progression of glomerulonephritis. Pediatr Nephrol 1992; 6: 292–303.CrossRefPubMedGoogle Scholar
  41. 41.
    Meyer BR, Fischbein A, Rosenman K, Lerman Y, Drayer DE, Reidenberg MM. Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am J Med 1984; 76: 989–998.PubMedGoogle Scholar
  42. 42.
    Askergen A. Studies in kidney function in subjects exposed to organic solvents. III. Excretion of cells in the urine. Acta Med Scand 1981; 210: 103–108.Google Scholar
  43. 43.
    Francini I, Cavatorta A, Folzoi M Lucertini S, Mutti A. Early indicators of renal damage in workers exposed to organic solvents. Int Arch Occup Environ Health 1983; 52: 1–9.Google Scholar
  44. 44.
    Lauwerys R, Bernard A, Viau C, Buchet JP. Kidney disorders and hemotoxicity from organic solvent exposure. Scan J Work Environ Health 1985; II (suppl 1): 84–90.Google Scholar
  45. 45.
    Ravnskov U. Possible mechanism of hydrocarbon-associated glomerulonephritis. Clin Nephrol 1985; 23: 294–298.PubMedGoogle Scholar
  46. 46.
    Bekesi JG, Holland JF, Anderson HA, Fischbein AS, Rom W, Wolff MS, Selikoff IJ. Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science 1978; 199: 1207–1209.PubMedGoogle Scholar
  47. 47.
    Peters DK, Lachmann PJ. Immunity deficiency in the pathogenesis of glomerulonephritis. Lancet 1974; 1: 58–61.PubMedGoogle Scholar
  48. 48.
    Shibita S, Yokoyama M. Nephritogenic glycoproteins. Nephron 1990; 55: 152–158.Google Scholar
  49. 49.
    Glassock RJ, Lachmann PJ, Watson JI, Dixon FJ. Autologous immune complex nephritis induced by renal tubular antigens. J Exp Med 1986; 127: 573–587.Google Scholar
  50. 50.
    Klavis G, Drommer W. Goodpasture’s syndrome and the effects of benzene. Arch Toxicol 1970; 26: 40–55.Google Scholar
  51. 51.
    Harman JW, Miller EC, Miller JA. Chronic glomerulonephritis and nephrotic syndrome induced in rats by N, N′-diacetylbenzidine. Am J Pathol 1952; 28: 529.Google Scholar
  52. 52.
    Harman JW. Chronic glomerulonephritis and nephrotic syndrome induced in rats with N, N′-diacetylbenzidine. J Pathol 1970; 104: 119–128.Google Scholar
  53. 53.
    Zimmerman SW, Norbach DH. Nephrotoxic effects of long term carbon tetrachloride administration in rats. Arch Pathol Lab Med 1980; 104: 94–99.PubMedGoogle Scholar
  54. 54.
    Epstein E. The anomaly of silicon in plant biology. Proc Natl Acad Sci 1994; 91: 11–17.PubMedGoogle Scholar
  55. 55.
    Slavin RE, Swedo JL, Brandes D, Gonzalez-Vitale JC, Osornio-Vargas A. Extrapulmonary silicosis: a clinical, morphologic, and ultrastructural study. Hum Pathol 1985; 16: 393–412.PubMedGoogle Scholar
  56. 56.
    Osorio AM, Thun MJ, Novak RF, Van Cura EJ, Avner ED. Silica and glomerulonephritis: case report and review of the literature. Am J Kidney Dis 1987; 9(3): 224–230.PubMedGoogle Scholar
  57. 57.
    Bonnin A, Mousson C, Justrabo E, Tanter Y, Chalopin JM, Rifle G. Silicosis associated with crescentic IgA mesangial nephropathy. Nephron 1987; 47: 229–230.PubMedGoogle Scholar
  58. 58.
    Sherson D, Jorgensen F. Rapidly progressive crescenteric glomerulonephritis in a sandblaster with silicosis. Brit J Ind Med 1989; 46: 675–676.Google Scholar
  59. 59.
    Arnalich F, Lahoz C, Picazo ML, Monerero A, Arribas JR, Martinez Ara J, Vazques JJ. Polyarteritis nodosa and necrotizing glomerulonephritis associated with long-standing silicosis. Nephron 1989; 51: 544–547.PubMedGoogle Scholar
  60. 60.
    Dracon M, Noel C, Wallaert B, Dequiedt P, Lelievre G, Tacquet A. Glomérulonéphrites rapidement progressives chez les mineurs de charbon pneumoconiotiques. Néphrologie 1990; 11: 61–65.PubMedGoogle Scholar
  61. 61.
    Gregorini G, Tira P, Lancini L, Bozzola G, Maiorca R. Silica exposure as a risk factor in the development of necrotising and crescentic glomerulonephritis with anti-mieloperoxidase antibodies. Nephrol Dial Transplant 1991; 6: 773 (abstract).Google Scholar
  62. 62.
    Neyer U, Wöss E, Neuweiler J. Wegener’s granulomatosis associated with silicosis. Nephrol Dial Transplant 1994; 9: 559–561.PubMedGoogle Scholar
  63. 63.
    Nakajima H, Miyazaki M, Imai N, Yokokawa T, Yamamoto S. A case of silicosis with MPO-ANCA-associated glomerulonephritis and alveolar hemorrhage. Nippon Jinzo Gakkai Shi 2001; 43: 351–356.PubMedGoogle Scholar
  64. 64.
    Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nunez-Roldan A. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 1993; 52: 534–538.PubMedGoogle Scholar
  65. 65.
    Calvert GM, Steenland K, Palu S. End-stage renal disease among silica-exposed gold miners. A new method for assessing incidence among epidemiologic cohorts. JAMA 1997; 277: 1219–1223.CrossRefPubMedGoogle Scholar
  66. 66.
    Ng TP, Ng YL, Lee HS, Chia KS, Ong HY. A study of silica nephrotoxicity in exposed silicotic and non-silicotic workers. Brit J Ind Med 1992, 49: 35–37.Google Scholar
  67. 67.
    Boujemaa W, Lauwerys R, Bernard A. Early indicators of renal dysfunction in silicotic workers. Scand J Work Environ Health 1994; 20: 188–191.Google Scholar
  68. 68.
    Rosenman KD, Moore-Fuller M, Reilly MJ. Kidney disease and silicosis. Nephron 2000; 85: 14–19.CrossRefPubMedGoogle Scholar
  69. 69.
    Hotz P, Gonzalez-Lorenzo J, Siles E, Trujillano G, Lauwerys R, Bernard A. Subclinical signs of kidney dysfunction following short exposure to silica in the absence of silicosis. Nephron 1995; 70: 438–442.PubMedGoogle Scholar
  70. 70.
    Marsh GM, Enterline PE, Stone RA, Henderson VL. Mortality among a cohort of U.S. manmade mineral fiber workers: 1985 follow-up. J Occup Med 1985; 32: 594–604.Google Scholar
  71. 71.
    Goldsmith JR, Goldsmith DF. Fiberglass or silica exposure and increased nephritis or end-stage renal disease. Am J Ind Med 1993; 23: 873–881.PubMedGoogle Scholar
  72. 72.
    Steenland NK, Thun MJ, Ferguson CW, Port FK. Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health 1990; 80: 153–159.PubMedGoogle Scholar
  73. 73.
    Gregorini G, Ferioli A, Donato F, Tira P, Morassi L, Tardanico R, Lancini L, Maiorca R. Association between silica exposure and necrotizing crescentic glomerulonephritis with P-ANCA and anti-MPO antibodies: a hospital-based case-control study. Adv Exp Med Biol 1993; 336: 435–439.PubMedGoogle Scholar
  74. 74.
    Nuyts GD, Van Vlem E, De Vos A, Daelemans RA, Rorive G, Elseviers MM, Schurgers M, Segaert M, D’Haese PC, De Broe ME. Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study. Nephrol Dial Transplant 1995; 10: 1162–1165.PubMedGoogle Scholar
  75. 75.
    Steenland K, Sanderson W, Calvert GM. Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology 2001; 12: 405–412CrossRefPubMedGoogle Scholar
  76. 76.
    Stratta P, Messuerotti A, Canavese C, Coen M, Luccoli L, Bussolati B, Giordia L, Malavenda P, Cacciabu M, Bugiani M, Bo M, Ventura M, Camussi G, Fubini B. The role of metals in autoimmune vasculitis: epidemiological and pathogenic study. Sci Total Environ 2001; 270: 179–190.CrossRefPubMedGoogle Scholar
  77. 76a.
    Hogan SL, Satterly KK, Dooley MA, Nachman PH, Jennette JC, Falk RJ. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 2001; 12: 134–142.PubMedGoogle Scholar
  78. 77.
    Hauglustaine, Van Damme B, Daenens P, Michielsen P. Silicon nephropathy: a possible occupational hazard. Nephron 1980; 26: 219–224.PubMedGoogle Scholar
  79. 78.
    Kallenberg CGM. Renal disease-another effect of silica exposure. Nephrol Dial Transplant 1995; 10: 1117–1119 (Editorial Comment).PubMedGoogle Scholar
  80. 79.
    Warheit DB, Driscoll KE, Oberdoerster G, Walker C, Kuschner M, Hesterberg TW. Symposium overview. Contemporary issues in fiber toxicology. Fund Appl Toxicol 1995; 25: 171–183.CrossRefGoogle Scholar
  81. 80.
    Schainkin-Kerstenbaum R, Adler AJ, Berlyne GM. Inhibition of superoxide dismutase activity by silicon. J Trace Elem Electrolytes Health Dis 1990; 4: 97–99.Google Scholar
  82. 81.
    Fubini B, Bolis V, Giamell E, Volante M. Chemical functionalities at the broken fiber surface relatable to free radical production. In: Mechanisms in fibre carcinogenisis. Brown RC, editor. Plenum Press, New York 1991, p.Google Scholar
  83. 82.
    Fubini B. The possible role of surface chemistry in the toxicity of inhaled fibres. In: Fiber toxicology. Warheit DB (editor). Academic Press, San Diego 1993; p. 229–257.Google Scholar
  84. 83.
    Tervaert JWC, Stegeman CA, Kallenberg CGM. Silicon exposure and vasculitis. Current Opinion Rheumatol 1998; 10: 12–17.Google Scholar
  85. 84.
    Gilligan HM, Bredy B, Brady HR, Hebert MJ, Slayter HS, Xu Y, Rauch J, Shia MA, Koh JS, Levine JS. Antineutrophil cytoplasmatic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996; 184: 2231–2241.CrossRefPubMedGoogle Scholar
  86. 85.
    Iyer R, Hamilton RF, Li L, Holian A. Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages. Toxicol Appl Pharmacol 1996; 141: 84–92.PubMedGoogle Scholar
  87. 86.
    Yang JJ, Tuttle R, Taylor JG, Jennette JC, Falk RJ. ANCA target antigens are not on the surface of normal neutrophils but are present on both primed and apoptotic neutrophils. J Am Soc Nephrol 1997; 8; 546 (abstract).Google Scholar
  88. 87.
    Ueki A, Yamaguchi M, Ueki H, Watanabe Y, Ohsawa G, Kinuguwa K, Kawakami Y, Hyodoh F. Polyclonal human T-cell activation by silicate in vitro. Immunology 1994; 82: 332–335.PubMedGoogle Scholar
  89. 88.
    Shiffenbauer J, Johnson H, Soos J. Superantigens in autoimmunity: their role as etiologic and therapeutic agents. In: Superantigens: Molecular biology, immunology, and relevance to human disease. Leung DYM, Huber BT, Schlievert PM (editors). Marcel Dekker, New York 1997; p. 525–549.Google Scholar
  90. 89.
    Elseviers MM, De Schepper A, Corthouts R, Bosmans JL, Cosyn L, Lins RL, Lornoy W, Matthys E, Roose R, Van Caesbroeck D, Waller I, Horackova M, Schwarz A, Svrcek P, Bonucchi D, Franek E, Morlans M, De Broe ME. High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure. Kidney Int 1995 48 1316–1323.PubMedGoogle Scholar
  91. 90.
    Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin and nonsteroidal antiinlammatory drugs. New Engl J Med 1994; 331: 1675–1679.CrossRefPubMedGoogle Scholar
  92. 91.
    Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PN, Signorello LB, Lipworth L, Elinder CG, Blot WJ, McLaughlin JK, Zack MM, Nyrén O. N Engl J Med 2001; 345: 1801–1808.CrossRefPubMedGoogle Scholar
  93. 92.
    Abuelo JG. Renal failure caused by chemicals, foods, plants, animal venoms, and misuse of drugs. Arch Intern Med 1990; 150: 505–510.CrossRefPubMedGoogle Scholar
  94. 93.
    Vanholder R, Colardyn F, De Reuck J, Praet M, Lameire N, Ringoir S. Diquat intoxication: report of two cases and review of the literature. Am J Med 1981; 70: 1267–1271.CrossRefPubMedGoogle Scholar
  95. 94.
    Poisoning: toxicology, symptoms, treatments. Arena JM, Drew RH, editors. Charles C Thomas Publ, Springfield Ill 1983; p. 177–179.Google Scholar
  96. 95.
    Munk ZM, Nantel A. Acute lindane poisoning with development of muscle necrosis. Can Med Assoc J 1977; 117: 1050–1052.PubMedGoogle Scholar
  97. 96.
    Nash RG, Kearney PC, Maitlen JC, Sell CR, Fertig SN. Agricultural applicators exposure to 2, 4-Dichlorophenoxyacetic acid. In: Pesticide residues and exposure. Plimmer JR, editor. ACS symposium series #182, 1982, Chap 10: 119–132.Google Scholar
  98. 97.
    Kolmodin-Hedman B, Hoglund S, Akerblom M. Studies on phenoxy acid herbicides. I. Field study. Occupational exposure to phenoxy acid herbicides (MCPA, dichlorprop, mecoprop and 2, 4-D) in agriculture. Arch Toxicol 1983; 54(4): 257–265.PubMedGoogle Scholar
  99. 98.
    Kolmodin-Hedman B, Hoglund S, Swensson A, Akerblom M. Studies on phenoxy acid herbicides. II. Oral and dermal uptake and elimination in urine of MCPA in humans. Arch Toxicol 1983; 54(4): 267–273.PubMedGoogle Scholar
  100. 99.
    Libich S, To JC, Frank R, Sirons GJ. Occupational exposure of herbicide applicators to herbicides used along electric power transmission line right-of-way. Am Ind Hyg Assoc J 1984; 45: 56–62.PubMedGoogle Scholar
  101. 100.
    Manninen A, Kangas J, Klen T, Savolainen H. Exposure of finnish farm workers to phenoxy acid herbicides. Arch Envir Contam Toxicol 1986; 15: 107–111.Google Scholar
  102. 101.
    Kancir CB, Andersen C, Olesen AS. Marked hypocalcemia in a fatal poisoning with chlorinated phenoxy acid derivatives. Clin Toxicol 1988; 26: 257–264.Google Scholar
  103. 102.
    Berndt WO, Koschier F. In vitro uptake of 2, 4-dichlorophenoxyacetic acid (2, 4-D) and 2, 4, 5-trichlorophenoxyacetic acid (2, 4, 5-T) by renal cortical tissue of rabbits and rats. Toxicol Appl Pharmacol 1973; 26: 559–570.CrossRefPubMedGoogle Scholar
  104. 103.
    Chugh KS, Singhal PC, Nath IVS, Pareek SK, Ubroi HS, Sarkar AK. Acute renal failure due to non-traumatic rhabdomyolysis. Postgrad Med J 1979; 55: 386–392.PubMedGoogle Scholar
  105. 104.
    Averbukh Z, Modai D, Leonov V, Weissgarten J. Rhabdomyolysis and acute renal failure induced by paraphenylenediamine. Hum Toxicol 1989; 8: 345–348.PubMedGoogle Scholar
  106. 105.
    Talbot AR, Shiaw MH, Huang JS, Yang SF, Goo TS, Wang SH, Chen CL, Sanford TR. Acute poisoning with a glyphosate-surfactant herbicide (‘Round-up’): a review of 93 cases. Hum Exper Toxicol 1991; 10; 1–8.Google Scholar
  107. 106.
    De Broe ME, D’Haese PC, Nuyts GD, Elseviers MM. Occupational renal diseases. Current Opinion Nephrol Hypert 1966; 5: 114–121.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Patrick C. D’haese
    • 1
  • Monique M. Elseviers
    • 1
  • Muhammed Yaqoob
    • 2
  • Marc E. De Broe
    • 1
  1. 1.University of AntwerpBelgium
  2. 2.The Royal London HospitalLondonUK

Personalised recommendations